William L. Macias is Chief Medical Officer at Immunovant, Inc. (IMVT). They have made 21 open-market trades across 1 company since 2022, most recently 2025-02-19.
CIK 0001864280
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMVT | 357,353 | $9.6M |
Shares reported on the most recent Form 4, priced at the 2025-02-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2025-02-19 | 2025-02-21 | $20.86 | $43K | -8.4% | -8.3% | -31.4% |
| IMVT | SELL | 2025-01-15 | 2025-01-17 | $23.83 | $57K | -8.2% | -13.4% | -37.0% |
| IMVT | SELL | 2024-11-20 | 2024-11-22 | $25.45 | $171K | +4.4% | -5.3% | -24.8% |
| IMVT | SELL | 2024-10-16 | 2024-10-18 | $28.79 | $167K | +2.3% | -13.6% | -19.3% |
| IMVT | SELL | 2024-08-21 | 2024-08-23 | $31.85 | $189K | +3.8% | -12.5% | -18.1% |
| IMVT | SELL | 2024-07-17 | 2024-07-19 | $29.67 | $160K | +3.1% | +10.6% | +3.8% |
| IMVT | SELL | 2024-05-22 | 2024-05-24 | $29.65 | $193K | -12.7% | -6.1% | +7.8% |
| IMVT | SELL | 2024-04-17 | 2024-04-19 | $29.06 | $471K | -0.2% | +8.0% | -0.6% |
| IMVT | SELL | 2024-02-22 | 2024-02-23 | $36.15 | $161K | -9.8% | -14.8% | -22.5% |
| IMVT | SELL | 2024-01-18 | 2024-01-19 | $41.03 | $17K | -10.2% | -7.5% | -30.1% |
| IMVT | SELL | 2023-11-22 | 2023-11-24 | $32.76 | $210K | +16.8% | +32.2% | +7.7% |
| IMVT | SELL | 2023-10-19 | 2023-10-20 | $36.80 | $20K | -1.2% | -0.2% | +19.7% |
| IMVT | SELL | 2023-08-24 | 2023-08-25 | $20.30 | $501K | +14.7% | +1.1% | +66.6% |
| IMVT | SELL | 2023-07-19 | 2023-07-20 | $24.94 | $11K | +0.0% | -10.8% | +60.2% |
| IMVT | SELL | 2023-04-25 | 2023-04-26 | $16.29 | $8K | +20.4% | +31.2% | +35.5% |
| IMVT | SELL | 2023-02-02 | 2023-02-03 | $18.24 | $10K | +0.9% | -6.4% | +5.7% |
| IMVT | SELL | 2023-01-11 | 2023-01-13 | $16.75 | $746K | -3.5% | -0.8% | -15.8% |
| IMVT | SELL | 2022-10-21 | 2022-10-25 | $9.67 | $3K | +15.9% | +27.1% | +71.2% |
| IMVT | SELL | 2022-07-22 | 2022-07-26 | $4.70 | $2K | +11.5% | +49.2% | +151.1% |
| IMVT | SELL | 2022-04-19 | 2022-04-20 | $4.98 | $7K | -6.5% | -20.7% | -14.0% |
| IMVT | SELL | 2022-01-05 | 2022-01-07 | $8.28 | $444K | -14.3% | -25.7% | -35.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.